FP & A Intern
Danaher Corporation
Summary
The FP&A Intern will support the Finance team in providing financial analysis, forecasting, and reporting to help drive business decision-making. This role will collaborate cross-functionally to analyze financial performance, identify process improvement opportunities, and support automation initiatives.
Job description
The intern will assist with monthly close activities, financial modeling, variance analysis, and the preparation of management reports. This position offers valuable exposure to business operations, strategic planning, and financial analysis within a dynamic organization.
This position is part of the Finance Department located in Fargo, ND and will be on-site. You will be a part of the FP&A team and report to the Sr. Manager of Finance responsible for budgeting, forecasting, monthly/quarterly close activities, variance analysis, and delivering executive-ready insights.
The essential requirements of the job include:
- Currently pursuing a bachelor’s degree in Finance/Accounting or related field
- Strong analytical and problem-solving skills
It would be a plus if you also possess previous experience in:
- Microsoft Excel and other Office applications
- OneStream or other financial systems
Requirements
- Currently pursuing a bachelor’s degree in Finance/Accounting or related field
- Strong analytical and problem-solving skills
- Microsoft Excel and other Office applications
- OneStream or other financial systems
Benefits
- Paid internship
- Bonus/incentive pay
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.